You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
The researchers are following up on earlier NIH-funded work examining microRNAs as potential indicators of clinical outcomes of heart disease patients.
In PNAS this week: genetic variation, environmental factors influence infants' attention to emotion, role for miR-150 in maintaining normal retinal blood vessel repertoires, and more.
The grant is being provided under the NIH's Extracellular RNA Communication program, which was set up to study the role of molecules such as microRNAs.
This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.
The team recently received funding to develop and validate an assay to help guide clinical decision making when pancreatic cancer precursor lesions are detected.
In Science this week: yeast spliceosome structure, and more.
The partners will further develop a non-invasive, blood-based test for the early detection of lung cancer.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers identified genomic and transcriptomic categories for cutaneous melanoma through an integrated analysis of some 300 primary or metastatic tumors.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.